Back
LyondellBasell Industries NV Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Sell
30
LYB
LyondellBasell Industries NV
Last Price:
$47.64
Seasonality Move:
5.17%
Sell
38
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.22
Seasonality Move:
-13.28%
Sell
30
LyondellBasell Industries NV (LYB)
is a Sell
Is LyondellBasell Industries NV a Buy, Sell or Hold?
-
The current LyondellBasell Industries NV [LYB] share price is $44.91. The Score for LYB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
LYB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYB Stock Price Chart
What is LyondellBasell Industries NV's stock price today?
-
The LyondellBasell Industries NV share price today is $44.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYB is experiencing slight selling pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 52.7 | Buy |
| Chaikin Money Flow: | -1452952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.7 - 45.32) | Buy |
| Bollinger Bands (100): | (43.48 - 52.48) | Sell |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 66.03 | Buy |
| Chaikin Money Flow: | 3428689 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.13 - 49.63) | Buy |
| Bollinger Bands (100): | (35.09 - 47.19) | Buy |
LYB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.34 | Buy |
| 20-day SMA: | 43.88 | Buy |
| 50-day SMA: | 44.62 | Buy |
| 200-day SMA: | 53.63 | Sell |
| 8-day EMA: | 44.61 | Buy |
| 20-day EMA: | 44.27 | Buy |
| 50-day EMA: | 45.2 | Sell |
| 200-day EMA: | 54.72 | Sell |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.2 | Buy |
| 20-day SMA: | 48.28 | Buy |
| 50-day SMA: | 45.42 | Buy |
| 200-day SMA: | 36 | Buy |
| 8-day EMA: | 48.68 | Buy |
| 20-day EMA: | 47.84 | Buy |
| 50-day EMA: | 45.56 | Buy |
| 200-day EMA: | 40.15 | Buy |
LyondellBasell Industries NV Earnings Growth & LYB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and an increase next year of $1.39 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.55 per share.
LyondellBasell Industries NV Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||